Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Linda Granger"'
Autor:
Koichi Iijima, Hsueh-Cheng Chiang, Stephen A Hearn, Inessa Hakker, Anthony Gatt, Christopher Shenton, Linda Granger, Amy Leung, Kanae Iijima-Ando, Yi Zhong
Publikováno v:
PLoS ONE, Vol 3, Iss 2, p e1703 (2008)
Aggregation of the amyloid-beta-42 (Abeta42) peptide in the brain parenchyma is a pathological hallmark of Alzheimer's disease (AD), and the prevention of Abeta aggregation has been proposed as a therapeutic intervention in AD. However, recent report
Externí odkaz:
https://doaj.org/article/6ac9f0014d1c45a1a2a3f517597fc1ea
Autor:
Anthony Gatt, Inessa Hakker, Kanae Iijima-Ando, Hsueh Cheng Chiang, Koichi M. Iijima, Christopher Shenton, Yi Zhong, Linda Granger, Stephen Hearn
The amyloid-beta42 (Abeta42) peptide has been suggested to play a causative role in Alzheimer disease (AD). Neprilysin (NEP) is one of the rate-limiting Abeta-degrading enzymes, and its enhancement ameliorates extracellular amyloid pathology, synapti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84f622a995e77fe2f8cfcf307c896918
https://europepmc.org/articles/PMC2441542/
https://europepmc.org/articles/PMC2441542/
Autor:
Linda Granger, Anthony Gatt, Koichi M. Iijima, Yi Zhong, Stephen Hearn, Amy Leung, Hsueh Cheng Chiang, Kanae Iijima-Ando, Christopher Shenton, Inessa Hakker
Publikováno v:
PLoS ONE, Vol 3, Iss 2, p e1703 (2008)
PLoS ONE
PLoS ONE
Aggregation of the amyloid-beta-42 (Abeta42) peptide in the brain parenchyma is a pathological hallmark of Alzheimer's disease (AD), and the prevention of Abeta aggregation has been proposed as a therapeutic intervention in AD. However, recent report
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72d000d78724d52c3b1cb66a13207a72
http://europepmc.org/articles/PMC2250771?pdf=render
http://europepmc.org/articles/PMC2250771?pdf=render